Ghent University Academic Bibliography

Journal Article
A1
open access

BrainPepPass : a framework based on supervised dimensionality reduction for predicting blood-brain barrier-penetrating peptides

Ewerton Cristhian Limade Oliveira, Hannah Hirmz (UGent) , Evelien Wynendaele (UGent) , Juliana Auzier Seixas Feio, Igor Matheus Moreira, Kauê Santana da Costa, Anderson H. Lima, Bart De Spiegeleer (UGent) and Claudomiro de Souza de Sales Júnior

(2024) JOURNAL OF CHEMICAL INFORMATION AND MODELING.

Add to list

Streptococcal quorum sensing peptide CSP-7 contributes to muscle inflammation and wasting

Anton De Spiegeleer (UGent) , Amélie Descamps (UGent) , Evelien Wynendaele (UGent) , Petar Naumovski, Liesbeth Crombez (UGent) , Marta Planas, Lidia Feliu, Daniel Knappe, Vincent Mouly, Anne Bigot, et al.

(2024) BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 1870(4).

Add to list

The continuing challenge of drug recalls: insights from a ten-year FDA data analysis

Seppe Ghijs (UGent) , Evelien Wynendaele (UGent) and Bart De Spiegeleer (UGent)

(2024) JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS. 249.

Add to list

Potential role of statins in treatment of acute sarcopenia

Anton De Spiegeleer (UGent) , Hasan Kahya, Liesbeth Crombez (UGent) , Amélie Descamps (UGent) , Roland Rössler, Reto W. Kressig, Bruno Lapauw (UGent) , Evelien Wynendaele (UGent) , Dirk Elewaut (UGent) , Bart De Spiegeleer (UGent) , et al.

(2023) MEDICAL HYPOTHESES. 177.

Add to list

Journal Article
A1
open access

Peptidomics : LC-MS operational parameters do matter

Amélie Descamps (UGent) , Kevin Van der borght (UGent) , Anton De Spiegeleer (UGent) , Evelien Wynendaele (UGent) and Bart De Spiegeleer (UGent)

(2023) JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS. 229.

Add to list

Journal Article
A1
open access

Characterizing non-covalent protein complexes using asymmetrical flow field-flow fractionation on-line coupled to native mass spectrometry

Iro Konstantina Ventouri, Wayne Chang, Florian Meier, Roland Drexel, Govert W. Somsen, Peter J. Schoenmakers, Bart De Spiegeleer (UGent) , Rob Haselberg and Alina Astefanei

(2023) ANALYTICAL CHEMISTRY. 95(19). p.7487-7494

Add to list

Journal Article
A1
open access

Emerging pharmaceutical therapies of Ascidian-derived natural products and derivatives

Kris Cooreman, Bart De Spiegeleer (UGent) , Christof Van Poucke, David Vanavermaete, Daan Delbare, Evelien Wynendaele (UGent) and Bavo De Witte

(2023) ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY. 102.

Add to list

Journal Article
A1
open access

Evaluation of greenness and analytical performances of separative methods for chiral separation of novel lactam-based P2RX7-antagonists

Lorenzo Avigo, Christophe Furman, Alina Ghinet, Teodora Sandu, Evelien Wynendaele (UGent) , Bartosz Wielgomas, Bart De Spiegeleer (UGent) and Emmanuelle Lipka

(2023) ELECTROPHORESIS. 45(3-4). p.218-233

Add to list

Journal Article
A1
open access

Environment-functionality-cost balance of an analytical reagent

Hannah Hirmz (UGent) , Frederick Verbeke, Bartosz Wielgomas (UGent) , Christophe Furman, Emmanuelle Lipka, Bart De Spiegeleer (UGent) and Evelien Wynendaele (UGent)

(2023) SUSTAINABLE CHEMISTRY AND PHARMACY. 32.

Add to list

Journal Article
A1
open access

Degradation kinetics of artesunate for the development of an ex-tempore intravenous injection

Fanta Gashe Fufa (UGent) , Evelien Wynendaele (UGent) , Bart De Spiegeleer (UGent) and Sultan Suleman

(2022) MALARIA JOURNAL. 21(1).

Academic Bibliography

BrainPepPass : a framework based on supervised dimensionality reduction for predicting blood-brain barrier-penetrating peptides

Streptococcal quorum sensing peptide CSP-7 contributes to muscle inflammation and wasting

The continuing challenge of drug recalls: insights from a ten-year FDA data analysis

Potential role of statins in treatment of acute sarcopenia

Peptidomics : LC-MS operational parameters do matter

Characterizing non-covalent protein complexes using asymmetrical flow field-flow fractionation on-line coupled to native mass spectrometry

Emerging pharmaceutical therapies of Ascidian-derived natural products and derivatives

Evaluation of greenness and analytical performances of separative methods for chiral separation of novel lactam-based P2RX7-antagonists

Environment-functionality-cost balance of an analytical reagent

Degradation kinetics of artesunate for the development of an ex-tempore intravenous injection

Contents

Support

Contact